Also trades as: MBXBF (OTC) · $vol 0M
MBX.TO TSX
Microbix Biosystems Inc.
1W: +1.7%
1M: +1.7%
3M: +0.0%
YTD: +30.4%
1Y: +27.7%
3Y: -6.2%
5Y: -53.9%
C$0.30 ($0.21)
-0.01 (-3.23%)
Weekly Expected Move ±6.6%
C$0
C$0
C$0
C$0
C$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$37M
-1.8% ▼
5Y CAGR: +19.1%
Total Liabilities
$10M
-1.8% ▼
5Y CAGR: +1.4%
Shareholders Equity
$28M
-1.8% ▼
5Y CAGR: +33.2%
Cash & Investments
$12M
-6.6% ▼
5Y CAGR: +165.0%
Total Debt
$7M
+5.9% ▲
5Y CAGR: +1.9%
Net Debt
-$5M
+18.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10M | $13M | $12M | $13M | $12M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $10M | $13M | $12M | $13M | $12M |
| Net Receivables | $4M | $3M | $4M | $4M | $2M |
| Inventory | $4M | $5M | $6M | $6M | $9M |
| Other Current Assets | $0 | $0 | $0 | $643K | $656K |
| Total Current Assets | $19M | $22M | $22M | $24M | $24M |
| Property, Plant & Equip. | $8M | $9M | $9M | $10M | $10M |
| Goodwill & Intangibles | $2M | $1M | $4M | $4M | $4M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | -$10M | $332K | $0 | $0 | $0 |
| Total Non-Current Assets | $10M | $11M | $13M | $14M | $14M |
| Total Assets | $29M | $33M | $36M | $38M | $37M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $2M | $2M | $3M | $2M |
| Short-Term Debt | $2M | $111K | $111K | $111K | $216K |
| Deferred Revenue | $743K | $555K | $0 | $490K | $585K |
| Other Current Liabilities | $0 | $0 | $2M | $0 | $0 |
| Total Current Liabilities | $5M | $3M | $4M | $3M | $3M |
| Long-Term Debt | $4M | $5M | $6M | $6M | $5M |
| Other Non-Current Liab. | $0 | $0 | $299K | $250K | $0 |
| Total Non-Current Liabilities | $5M | $6M | $7M | $6M | $7M |
| Total Liabilities | $10M | $8M | $11M | $10M | $10M |
| — Equity — | |||||
| Common Stock | $44M | $50M | $49M | $49M | $50M |
| Retained Earnings | -$39M | -$37M | -$37M | -$33M | -$36M |
| Accumulated OCI | $3M | $2M | $2M | $2M | $2M |
| Total Stockholders Equity | $19M | $25M | $25M | $28M | $28M |
| Total Liabilities & Equity | $29M | $33M | $36M | $38M | $37M |
| — Key Metrics — | |||||
| Total Debt | $8M | $6M | $7M | $6M | $7M |
| Net Debt | -$2M | -$8M | -$5M | -$7M | -$5M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |